These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7460809)

  • 41. [The effect of an original analog of the C-terminal fragment of vasopressin on the behavior of white rats].
    Ponomareva NS; Voskresenskaia OG; Kamenskiĭ AA; Golubovich VP; Ashmarin IP
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1998; 48(3):471-7. PubMed ID: 9700911
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
    Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T
    Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of the antinociceptive and anti-inflammatory activities of riboflavin in different experimental models.
    Bertollo CM; Oliveira AC; Rocha LT; Costa KA; Nascimento EB; Coelho MM
    Eur J Pharmacol; 2006 Oct; 547(1-3):184-91. PubMed ID: 16962092
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of cyclopentyladenosine on the orientation, exploratory, and emotional behavior of rats with model brain injury].
    Sufianova GZ; Sufianov AA; Shapkin AG; Usov LA
    Eksp Klin Farmakol; 2009; 72(2):20-3. PubMed ID: 19441722
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does repetitive Ritalin injection produce long-term effects on SD female adolescent rats?
    Lee MJ; Yang PB; Wilcox VT; Burau KD; Swann AC; Dafny N
    Neuropharmacology; 2009 Sep; 57(3):201-7. PubMed ID: 19540860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Behavioral and neurochemical profile of m-CPP following exposure to single restraint stress in rat.
    Samad N; Haleem DJ
    Acta Neurol Belg; 2009 Mar; 109(1):24-31. PubMed ID: 19402569
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Neurotoxicity in sodium azide poisoning].
    Fujimura T; Kobayashi H; Suzuki T; Sato I; Hara S
    Chudoku Kenkyu; 2002 Jul; 15(3):281-8. PubMed ID: 12415870
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Morphine sex-dependently induced place conditioning in adult Wistar rats.
    Karami M; Zarrindast MR
    Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anxiolytic- and antidepressant-like effects of an antagonist at glycineB receptors.
    Przegaliński E; Tatarczyńska E; Chojnacka-Wójcik E
    Pol J Pharmacol; 1998; 50(4-5):349-54. PubMed ID: 10091720
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modulation of behavior and NMDA-R1 gene mRNA expression in adult female mice after sub-acute administration of benzo(a)pyrene.
    Grova N; Valley A; Turner JD; Morel A; Muller CP; Schroeder H
    Neurotoxicology; 2007 May; 28(3):630-6. PubMed ID: 17397927
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antagonism of (+)WAY 100135 to behavioral, hypothermic and corticosterone effects induced by 8-OH-DPAT.
    Przegaliński E; Filip M; Budziszewska B; Chojnacka-Wójcik E
    Pol J Pharmacol; 1994; 46(1-2):21-7. PubMed ID: 7981767
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intranasal dopamine application increases dopaminergic activity in the neostriatum and nucleus accumbens and enhances motor activity in the open field.
    de Souza Silva MA; Topic B; Huston JP; Mattern C
    Synapse; 2008 Mar; 62(3):176-84. PubMed ID: 18081176
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Does fluororetinography permit evaluation of the action of drugs: myth or reality?].
    Nihard P
    Bull Soc Belge Ophtalmol; 1981; 192():93-102. PubMed ID: 6896665
    [No Abstract]   [Full Text] [Related]  

  • 54. The subcellular distribution of calcium and the effects of calcium-antagonists as evaluated with a combined oxalate-pyroantimonate technique.
    Borgers M; Thoné F; van Nueten JM
    Acta Histochem Suppl; 1981; 24():327-32. PubMed ID: 6165047
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effect of cinnarizine on the brain mitochondrial oxidative system, antioxidant blood activity, and the rat behavior in hypoxia].
    Belostotskaia LI; Chaĭka LA; Gomon ON
    Eksp Klin Farmakol; 2003; 66(6):16-9. PubMed ID: 14743704
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of cinnarizine on nystagmus induced by rotation-deceleration.
    Cobb S; Coen LW; Gitomer SL; Iles R
    Eye Ear Nose Throat Mon; 1976 Jan; 55(1):48-30. PubMed ID: 1245202
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of pharmacological agents on erythrocyte deformability and endothelial cell injury.
    De Clerck F
    J Cereb Blood Flow Metab; 1982; 2 Suppl 1():S50-2. PubMed ID: 7085799
    [No Abstract]   [Full Text] [Related]  

  • 58. Study on the anti-hypoxic effect of cinnarizine and its interaction with prostacyclin.
    Nikolov R; Nikolova M; Milanova D
    Methods Find Exp Clin Pharmacol; 1984 Mar; 6(3):135-8. PubMed ID: 6379343
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An upper limit to the number of calcium channels in smooth muscle as estimated with cinnarizine.
    Godfraind T; Morel N
    Eur J Pharmacol; 1977 Jan; 41(2):245-6. PubMed ID: 832679
    [No Abstract]   [Full Text] [Related]  

  • 60. Peripheral vascular disease: cinnarizine et al.
    Drug Ther Bull; 1981 Mar; 19(7):27-8. PubMed ID: 7227205
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.